C G Musso
Overview
Explore the profile of C G Musso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hamzah L, Williams D, Bailey A, Jones R, Ibrahim F, Musso C, et al.
HIV Med
. 2019 Nov;
21(3):198-203.
PMID: 31679186
Objectives: The aim of the study was to assess the effect of tenofovir alafenamide (TAF) on kidney and bone biomarkers in patients who developed proximal renal tubulopathy (PRT) while receiving...
2.
Feder J, Gomez J, Serra-Aguirre F, Musso C
Indian J Nephrol
. 2019 Aug;
29(4):232-234.
PMID: 31423055
Reset osmostat (RO) consists of a change in the normal plasma osmolality threshold (reduction or increase), which consequently induces chronic dysnatremia (hyponatremia or hypernatremia). Although the early papers on RO...
3.
4.
Musso C, Vilas M, de Quiros F, Nunez J
Drug Res (Stuttg)
. 2015 Nov;
66(4):223-4.
PMID: 26575015
Ageing is characterized by a progressive loss of complexity, which is an essential condition for making the organism capable of keeping homeostasis. Thus, senile loss of complexity makes old individuals...
5.
Syndrome of rapid onset end stage renal disease in incident Mayo Clinic chronic hemodialysis patient
Onuigbo M, Onuigbo N, Musso C
Indian J Nephrol
. 2014 Apr;
24(2):75-81.
PMID: 24701038
Despite decades of research, a full understanding of chronic kidney disease (CKD)-end stage renal disease (ESRD) progression remains elusive. The common consensus is a predictable, linear, progressive and time-dependent decline...
6.
Figari M, Musso C, Plantalech L, Lambertini R, Rivera H, Mollerach A
Int Urol Nephrol
. 2013 Jan;
46(1):247-9.
PMID: 23359107
Secondary hyperparathyroidism (SHPT) is a serious complication in dialysis patients and is routinely managed with medical therapy. Refractory disease is usually treated either surgically or by local ethanol injection into...
7.
Musso C, Juarez R, Vilas M, Navarro M, Rivera H, Jauregui R
Int Urol Nephrol
. 2012 Aug;
44(5):1559-62.
PMID: 22893492
Introduction: It is known that chronic kidney disease (CKD) and senescence bring about a progressive reduction in glomerular filtration rate (GFR) and that in the former this is usually associated...
8.
Musso C, Jauregui R, Andresik D, Vilas M, Segalini A, Vazquez C
Int Urol Nephrol
. 2011 Apr;
43(2):611-2.
PMID: 21455764
No abstract available.
9.
Musso C, Reynaldi J, Martinez B, Pierangelo A, Mombelli C, Vilas M, et al.
Saudi J Kidney Dis Transpl
. 2011 Jan;
22(1):148-50.
PMID: 21196635
No abstract available.
10.
Musso C, Reynaldi J, Martinez B, Pierangelo A, Vilas M, Algranati L
Int Urol Nephrol
. 2010 Jul;
43(1):253-6.
PMID: 20593305
Introduction: Decline in glomerular filtration rate (GFR) is one of several changes in renal physiology in the elderly. Renal reserve (RR) is the kidney's capacity to increase its basal GFR...